Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_04420713d8ca0e51f499cd44298a4692 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5415 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5415 |
filingDate |
2010-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_760a0dbf4e58545755958fa73910c13d |
publicationDate |
2013-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20130037237-A |
titleOfInvention |
Use of Meloxycam for Long-Term Treatment of Musculoskeletal Disorders in Cats |
abstract |
The present invention relates to the use of a formulation comprising Meloxycham, or a pharmacologically acceptable Meloxycham salt of an organic or inorganic base thereof, for the long term treatment of musculoskeletal disorders in a cat. No negative effects on kidney function occur after 10-20 months or more of treatment. |
priorityDate |
2010-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |